Interestingly, alpinetin has been found to inhibit TNF-α expression, promote human pulmonary microvascular endothelial cell proliferation and increase the expression level of AQP1 thereby improving the SAP-induced ALI symptoms (Liang et al., 2016). The gene discussed is AQP1; the disease is acute respiratory distress syndrome.